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Nasal decongestants in Brazil are available without prescription. They are one of the most requested 
medications in Brazil. The use of nasal decongestants, however, may lead to serious consequences. 
For this study, university students majoring in the health field were evaluated in terms of their profile 
regarding the use of nasal decongestants. Additionally, health sciences seniors were evaluated regarding 
their level of knowledge concerning the correct and proper use of nasal decongestants. Among the 71.8% 
of respondents who had already used topic nasal decongestants, 64.3% had used this medication for at 
least 15 days and 64.6% had started using it due to nasal obstruction. The gathered data indicate that 
the pharmacist was the main health professional reported as having provided patients with guidance on 
how to use this medication. A five-point Likert Type intensity scale (3.6 ± 0.08) shows that a regular 
level of knowledge has been observed among the students. Most of the students polled were concluded 
to incorrectly use topic nasal decongestants. Furthermore, the results of this study indicate that the 
future health professionals are not well prepared to promote health education for patients concerning 
the rational use of nasal decongestants.
Uniterms: Nasal decongestans/use evaluation. Self-prescribed medication. Health education. 
Os descongestionantes nasais representam um dos grupos de medicamentos mais procurados dentro 
da automedicação no Brasil e as consequências ocasionadas pelo uso prolongado podem ser graves. 
Neste estudo foi aplicado a universitários da área de saúde um instrumento de avaliação para coleta 
de informações relacionadas ao perfil do uso destes medicamentos e outro instrumento para os alunos 
do último ano destas áreas para avaliar o nível de conhecimentos sobre o uso racional e correto 
dos descongestionantes nasais. Dos acadêmicos entrevistados, 71,8% fazem ou já fizeram o uso de 
descongestionantes nasais tópicos e destes, 64,3% utilizaram o medicamento por menos de 15 dias; 64,6% 
iniciaram o uso do descongestionante devido à obstrução nasal. Os dados obtidos ainda mostraram o 
farmacêutico como principal profissional responsável pela orientação do uso do medicamento aos usuários. 
Foi observado nível de conhecimento regular por parte dos alunos, através da escala de intensidade de 
cinco pontos do tipo Likert (3,6 ± 0,08). Conclui-se pelo uso incorreto de descongestionantes nasais 
tópicos pela maioria dos entrevistados e que falta preparo aos futuros profissionais para correta educação 
aos pacientes.
Unitermos: Descongestionantes nasais/avaliação do uso. Automedicação. Educação em saúde. 
INTRODUCTION
Decongestants are drugs that can act as sympathomi-
metic agents. They cause local vasoconstriction, thereby 
reducing congestion and edema of the nasal mucosa 
(Smith, Aronson, 2004). They are used to advance nasal 
obstruction in the common cold, sinusitis, fever, acute or 
chronic rhinitis, allergies of the upper respiratory tract, 
deviated septum, turbinate hypertrophy, nasal polyps and 
cancers (Zafanni et al., 2007).
Allergic rhinitis is one of the clinical situations in 
which nasal decongestants are used. It is a disease that af-
fects about 10% to 20% of the world population and 15% 
to 25% of children and adolescents (Castro, 2003).
Among the sympathomimetic vasoconstrictors for 
local application in the nose, imidazoles (naphazoline, 
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oxymetazoline, and xylometazoline) and catecholamine 
derivatives (epinephrine, ephedrine, and phenylephrine) 
are differentiated (Balbani et al., 2002). Both groups of na-
sal decongestants produce vasoconstriction by stimulation 
through the endogenous release of noradrenaline, which 
acts on alpha receptors (Corboz et al., 2008).
However, prolonged use of nasal decongestants 
leads to side effects, e.g. iatrogenic rhinitis. Therefore, the 
local application of vasoconstrictors may be used only for 
short periods of time (Bricks, Sih, 1999), and should not be 
used longer than four or five days, due to the risk of muco-
sal injury and rebound vasodilation (Arnold, 1992). In ad-
dition, prolonged use of decongestants leads to decreased 
sensitivity of alpha receptors, leading to a requirement of 
higher doses in shorter intervals in order to reach the same 
effect. Consequently, patients have started to use excessive 
doses of nasal decongestants (Doshi, 2008).
In Brazil, decongestants are a group of drugs most 
sought by patients for self-medication (Arrais et al., 1998). 
Self-medication becomes even more risky due to the fact 
that the population is poorly educated in regard to drugs 
and their correct use. Moreover, there is a lack of involve-
ment by health professionals who could offer guidance to 
users (Servidoni et al., 2006).
According to the Brazilian Association of Pharma-
ceutical Industries, millions of people self-medicate; this 
is mainly due to the fact that many drugs can be purchased 
without prescription. Concerning nasal decongestants, a 
possible reason why so many abuse them is the fast effi-
ciency of the drug (“personal experience”) (Bricks, 1995).
Additionally, the widespread availability and ease 
for purchasing the drug in pharmacies is another factor 
contributing to the inadequate use of nasal decongestants 
(Zafanni et al., 2007). This may have consequences for us-
ers, e.g., side effects, iatrogenic problems and progressive 
diseases. These processes have become a public problem 
to be identified and prevented (Servidoni et al., 2006).
Drugstore clerks offer advice on how to treat diseas-
es most frequently. This practice is routinely observed in 
cases of respiratory diseases, in which the clerk prescribes 
medicines without proper knowledge of the indications, 
contraindications, dosage, adverse effects and possible 
drug interactions (Balbani, Sanchez, Butugan, 1996; 
Balbani et al., 1996). Thus, self-medication and lack of 
information on nasal decongestants may endanger the 
health of its users.
The aim of this study was, therefore, to determine the 
frequency and character of the use of nasal decongestants 
in college health care. In addition, we assessed the level 
of knowledge about the rational use of these drugs in the 
last academic year of courses in this area.
METHODS
We conducted a cross-sectional study of quantitative 
and qualitative nature involving the academic health stu-
dents of a higher education institution in the state Espírito 
Santo, Brazil, between June and September 2009. Data 
was collected by using structured questionnaires. 
Sample calculation
The survey was conducted with students of medi-
cine, pharmacy, nutrition, nursing, speech therapy, phys-
iotherapy and physical education, through the stratified 
probabilistic method, in which the calculation of the 
sample was designed considering a confidence level of 
95% and a 5% sample error. For this study, data was 
gathered from 383 students. The assessment tools were 
administered after all subjects had fully agreed and signed 
the consent form. 
Evaluation of the frequency and profile of users
Through assessment tool I, the socio-economic-
cultural stage was calculated using parameters like sex, 
age, current occupation, and family income. The students 
answered questions related to the drug, e.g., habits of use, 
frequency of use, and reasons to use the drug.
During the last academic year, assessment tool 
II was also applied; it contained statements about the 
decongestants. The questionnaire assessed the level of 
technical knowledge these students possessed in terms 
of the rational use of nasal decongestants. True and false 
statements were presented to the students. The scale used 
in this tool consisted of a five-point Likert Type scale of 
intensity; the lowest number stands for “absolutely false” 
and the highest option means “absolutely true”. For the 
false statements, there was an inversion of the values for 
the calculation of the final score, e.g., if a student assigned 
a score of 1 to a false assertion, which was the correct 
answer; the score was then converted to five points.
From the data obtained by the questionnaires, the 
profile of the rational use of nasal decongestants and the 
level of knowledge of students from the last year of health 
care courses was determined.
Statistical analysis
The data were compiled into a spreadsheet devel-
oped in Microsoft Excel (Microsoft Office 2007). The data 
were analyzed using the SPSS Statistical Package Social 
Science version 11.5 (SPSS 11.5), where it performed 
Evaluation of the use of topic nasal decongestants in university students from health sciences courses 763
relative frequencies and simple cross. For the quantitative 
analysis, a one-way analysis of variance (ANOVA) was 
performed. The post-hoc test was used for Fisher’s mul-
tiple comparisons with a randomized design. These data 
were expressed as mean ± standard error of mean (S.E.M.).
RESULTS AND DISCUSSION
For this study, 383 students were interviewed, 71.8% 
(n = 275) of which had already made use of topical nasal 
decongestants. The gender breakdown of the student 
sample was 76.7% (n = 211) female and 23.3% (n = 64) 
male. Mean age was 22 ± 1 years. The majority of the users 
had an income of five times the minimum wage or more 
(49.6%, n = 190).
In Brazil, there is a high prevalence of nasal symp-
toms, accompanied by many prescriptions by physicians 
or self-medication (Balbani, Duarte, Montovani, 2004). 
These circumstances could explain the high percentage 
of subjects having already used nasal decongestants, as 
observed in this study. This is confirmed by the observa-
tion that nasal decongestants are among the most requested 
medications in Brazil, which is favored by the large supply 
and ease for purchasing this product freely in pharmacies 
and drugstores (Zafanni et al., 2007).
Taking only those patients who were or had been 
using nasal decongestant (71.8%, n = 275) into account, 
the duration of decongestant use was less than 15 days, 
followed by 15 days to a month (Table I). The highest 
frequency of use was seen in subjects who displayed 
symptoms of disease. The majority of these used it once 
per day (Table II).
The majority of users was experiencing symptoms 
and this could explain why decongestants are used for a 
long time, i.e., longer than the maximum of four to five 
days as suggested by Arnold (1992), at least. However, it 
is alarming to notice that 35.3% (n = 97) of respondents 
have used decongestants for more than 15 days, with a 
TABLE I - Duration of nasal decongestant use among the 
participants
Duration of use Quantity (n) Percentage (%)
Less than 15 days 178 64.7
15 to 30 days 39 14.2
2 to 6 months 14 5.1
7 to 12 months 9 3.3
2 to 5 years 11 4.0
more than 5 years 24 8.7
TABLE II - Frequency of use of nasal decongestant
Frequency of use Quantity (n) Percentage (%)
Once per day 40 14.5
Twice per day 37 13.5
3 times per day 37 13,5
4 time per day 13 4.7
5 or more times per day 8 2.9
Only with symptoms 130 47.3
Others 10 3.6
FIGURE 1 - Pharmacologically active substances used by the 
students interviewed.
substantial share of 12.7% (n = 35) having used it for more 
than two years. The latter patients are obviously endan-
gered, as the chronic use of this medicine may lead to a 
nasal congestion rebound effect and its prolonged use can 
lead to iatrogenic rhinitis (Bricks, Sih, 1999), and mucosal 
injury (Arnold, 1992).
A total of 25 types of medicinal topical nasal decon-
gestants have been described. The total number of such 
varieties used by respondents was 416, representing an 
average of 1.5 products per interviewee. Among the most 
cited were the adult Sorine® (32.2%, n = 134), Neosoro® 
(16.5%, n = 69), Rinosoro® (16.5%, n = 69), Afrin® 
(9.1%, n = 38) and Children Sorine® (6.9%, n = 29).
Grouping these medicines by active ingredients, it 
can be observed that the most frequently used by respon-
dents was the naphazoline hydrochloride (Adult Sorine®, 
Neosoro®, Naridrin®, Adnax®), followed by sodium 
chloride (Rinosoro®, Sorine Child®, Sorine H®) and 
oxymetazoline hydrochloride (Afrin® and Aturgyl®) 
(Figure 1).
As shown in Figure 1, 69.2% of the active ingre-
dients made up of vasoconstrictors such as naphazoline 
and oxymetazoline. This probably results from the fact 
that patients are seeking immediate and effective relief 
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for nasal congestion, and vasoconstrictors are known to 
promote a rapid and prolonged effect (Weckx et al., 1983). 
Nevertheless, there have been reports about neuropsychi-
atric effects caused by sympathomimetic amines found in 
systemic and topical decongestants (Balbani et al., 1997).
Products containing sodium chloride represent the 
second most nasal decongestants used by respondents. 
They offer advantages such as cleaning, removal of se-
cretions and reduction of local mucosal edema (Viertler 
et al., 2003) without the disadvantages described above 
for vasoconstrictors, and are therefore identified as a more 
rational alternative.
It was found that among the reasons for early use of 
the drug, nasal obstruction was the most frequent (Table 
III). Nasal obstruction is the most common symptom in 
patients with allergic rhinitis, a disease that affects a large 
percentage of the population, especially children and ado-
lescents, with a clinical situation where decongestants are 
used for providing quick relief (Castro, 2003).
Figure 2 shows the frequency distribution of who 
had recommended the nasal decongestant. Friends and 
relatives were accounted for 29% (n = 80) of recommenda-
tions. In 57% (n = 156) of cases, the statement was made 
by a health professional, mostly by a physician. Thus, one 
can verify that the drug had been prescribed by physicians 
in 47.0% (n = 130) of cases, 68.5% (n = 87) of which had 
offered guidance on how to use the drug.
A large proportion of the users was treated by fam-
ily members, which is understandable, from an economic 
perspective. However, the indication by others can cause 
problems like inadequate treatment, dissemination of 
inaccurate information, exposure to side effects, and en-
couragement of prolonged use of medications, which may 
lead to serious consequences (Arrais et al., 1998).
Another result of this study was that not many users 
consulted pharmacists for advice. Therefore, this study 
also provides information about indications, contrain-
dications, side effects and drug interactions. Clerks par-
ticipated substantially more frequently than pharmacists 
(Figure 2), but clerks do not often provide adequate advice 
to patients (Fields et al., 1985).
Among all users (n = 275) of nasal decongestants, 
65.3% (n = 181) had not received any guidance on how to 
use the drug. Among those who had not received guidance, 
56.9% (n = 99) had not followed the label directions for use 
of these drugs. The remaining 33.9% (n = 94) had received 
guidance, and the pharmacist, when compared to other 
professionals, showed the highest percentage of participa-
tion (Table IV). The main place where the decongestant 
was bought was the pharmacy (90.3%, n = 250) (Figure 3).
The results of this study clearly indicate that there 
is a lack of guidance for the rational use of decongestants, 
as more than 50% of the respondents had been given the 
medication without guidance on how to use it, and had not 
followed directions on the label. 
The present study shows evidence that the pharma-
cist is most frequently the person to provide guidance on 
the proper use of decongestants. Arrais and coworkers 
(2007) found that pharmacists play the most important 
role in yielding the information on how to correctly use 
a drug, both in the public and private sectors. In conclu-
sion, their presence helps to establish favorable guidance 
for patients, thus avoiding the guidance of clerks, who are 
TABLE III - Reasons for the use of nasal decongestants
Reasons for use Quantity (n) Percentage (%)
Nasal obstruction 179 65.0
Coryza 26 9.5
Sneezing 12 4.4
Itching nose 2 0.7
Others 17 6.2
More than one reason 39 14.2
TABLE IV - Persons who had offered advice on how to use nasal 
decongestants
Person who offered guidance Percentage (%)
Nurse 2.10 (n=3)
Pharmacist 60.00 (n=60)
Clerk 9.02 (n=13)
Others 38.88 (n=56)
More than one option 8.40 (n=12)
FIGURE 2 - Percentage of people who had recommended the 
drugs to users.
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FIGURE 3 - Main sites for purchasing nasal decongestants.
no longer authorized to perform this task (Barros, 1997).
The group of respondents who had made or was 
making use of other drugs along with the nasal deconges-
tant accounted for 39.7% (n = 110). The most used medi-
cations were analgesics (17.4%), followed cold medicine 
(16.6%), anti-thermal and antihistamine (14.2%), followed 
by anti-inflammatory drugs and antibiotics (10.3%). 
It was observed that 48.7% (n = 135) of users had 
health problems when using nasal decongestants. The 
main problems reported were cold / flu (22.6%, n = 59), 
sinusitis and allergies (16.5%, n = 43), rhinitis (16.1%, 
n = 42) and infections and inflammations of the throat 
(13.4%, n = 35).
It is well known that there is a wide acceptance of 
decongestants, topical or systemic corticosteroids, expec-
torants, cough suppressants and vitamins for the symptom-
atic treatment of colds and flu (Kennedy, Forbes, 1982). 
This may be the reason why of nasal decongestants – in 
combination with the other drugs mentioned above – are 
used for the main complaint reported by users. Bricks 
(1995) has pointed out that the associations most com-
monly used to treat cold/flu include decongestants and 
antihistamines. 
Users suffering from allergic rhinitis belong to the 
group which typically uses nasal decongestants (Castro, 
2003). Decongestants have proven useful in acute rhinitis, 
because its site of action is more selective, hence they 
tend to be abused, often resulting in rebound congestion 
(Gilman et al., 1996).
Among the respondents, 32.9% (n = 91) were aware 
of the dangers arising from the irrational use of nasal de-
congestants. Among the key risks highlighted by the inter-
viewees were the “addiction”, the rebound effect, damage 
to the nasal mucosa and tachycardia, among others.
Approximately 37.8% (n = 104) of students who use 
the decongestant make chronic use of medication. Among 
chronic users, 40.3% (n = 42) are motivated to stop the use, 
while the remaining 59.6% (n = 62) lacks this motivation.
The main reason for refusing to interrupt the chronic 
use of decongestants is the immediate comfort and relief 
of respiratory allergy symptoms the medicine offers, and 
the discomfort of the symptoms, mainly nasal obstruction. 
These results indicate a lack of knowledge on the risks of 
the chronic use of nasal decongestants, or a perception that 
the benefits outweigh the adverse effects.
The second questionnaire was administered to 165 
students who were in the last year of a health care course. 
Through the information provided, we have obtained a 
mean 3.46 ± 0.08 in the five-point Likert-type intensity 
scale. Table V shows the corresponding mean level of 
knowledge of academic health care contained in assess-
ment tool II.
The lowest mean scores by respondents are associ-
ated with questions regarding the prescription of vaso-
constrictors and the possibility of poisoning in children. 
Several studies have detected psychosis in children as a 
result from the use of decongestants, ceasing with the dis-
continuation of the drug (Balbani et al., 1997). Hence, the 
fact that decongestants can contribute to risk for children 
did not influence the users because only few participants 
knew about this kind of risk. Some studies also show that 
the high frequency of intoxication can be explained by 
the difficulty of administering nasal drops to children, 
who normally do not accept this sort of medication. As 
a consequence, parents often administer higher doses to 
ensure that the desired effect occurs (Balbani et al., 1997). 
One possibility to prevent these cases could be a coordi-
nated action, by health care professionals and educators, 
to educate and raise awareness on the proper use of these 
drugs (Balbani et al., 2004). 
Many students stated that nasal decongestants 
should be only available on prescription. The fact that the 
drugs are available without prescription may lead users to 
think that their use or abuse is free of risks or side effects 
(Balbani et al., 2004).
Despite these results, the study found higher mean 
scores for the following academic affirmative: “Nasal 
hygiene can be made by means of nasal instillation of sa-
line. It is an adjuvant form of treatment, simple and cheap, 
reduces the use of other medications, and should always 
be recommended”. 
CONCLUSION
From the results presented, we have concluded that 
the majority of respondents used or had been using nasal 
decongestants. A substantial share of participants who 
chronically used them was not motivated to stop using the 
drug, although prolonged use leads to serious complications. 
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Moreover, the students’ level of knowledge was considered 
insufficient, which may indicate that patients will not be 
sufficiently educated in the future, probably preventing the 
abuse to be diminished by a future generation of health care 
professionals. Therefore, coordinated actions are necessary 
in order to improve awareness on the proper use of nasal 
decongestants among health care students.
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